Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFC
3626
Ellington Financial
EFC
$1.67B
| $1.56M | ﹤0.01% |
113,182
-36,429
| -24% | -$464K |
|
3627
First Community Bankshares
FCBC
$900M
| $1.56M | ﹤0.01% |
52,508
+26,743
| +104% | +$703K |
|
|
APCA
3628
DELISTED
AP Acquisition Corp
APCA
| $1.56M | ﹤0.01% |
145,000
| – | – |
|
3629
NETSCOUT
NTCT
$2.96B
| $1.56M | ﹤0.01% |
50,355
-138,389
| -73% | -$4.07M |
|
3630
Box
BOX
$4.37B
| $1.55M | ﹤0.01% |
52,750
-25,911
| -33% | -$718K |
|
3631
Ouster
OUST
$2.63B
| $1.55M | ﹤0.01% |
+313,399
| New | +$1.64M |
|
3632
PUT
Hercules Capital
HTGC
$3.07B
| $1.55M | ﹤0.01% |
104,500
+32,300
| +45% | +$443K |
|
3633
Northwest Bancshares
NWBI
$2.3B
| $1.54M | ﹤0.01% |
145,445
-169,778
| -54% | -$1.89M |
|
3634
Ducommun
DCO
$2.7B
| $1.54M | ﹤0.01% |
35,359
-24,014
| -40% | -$1.13M |
|
3635
iShares MSCI USA Momentum Factor ETF
MTUM
$25B
| $1.54M | ﹤0.01% |
10,642
-14,859
| -58% | -$2.09M |
|
|
NVEE
3636
DELISTED
NV5 Global
NVEE
| $1.53M | ﹤0.01% |
55,396
+38,140
| +221% | +$936K |
|
3637
Stem
STEM
$48.4M
| $1.53M | ﹤0.01% |
13,394
-54,470
| -80% | -$5.41M |
|
|
SHCO
3638
DELISTED
Soho House & Co
SHCO
| $1.53M | ﹤0.01% |
281,902
-85,704
| -23% | -$540K |
|
3639
Utah Medical Products
UTMD
$225M
| $1.52M | ﹤0.01% |
16,356
+8,205
| +101% | +$773K |
|
|
SPR
3640
PUT
DELISTED
Spirit AeroSystems
SPR
| $1.52M | ﹤0.01% |
52,200
+1,000
| +2% | +$28.8K |
|
3641
NatWest
NWG
$75.4B
| $1.52M | ﹤0.01% |
248,354
-97,097
| -28% | -$638K |
|
3642
WaFd
WAFD
$2.72B
| $1.52M | ﹤0.01% |
+57,190
| New | +$1.58M |
|
3643
PUT
Bio-Rad Laboratories Class A
BIO
$8.71B
| $1.52M | ﹤0.01% |
4,000
+1,800
| +82% | +$733K |
|
3644
Marvell Technology
MRVL
$168B
| $1.52M | ﹤0.01% |
25,359
-7,315
| -22% | -$355K |
|
|
SII
3645
Sprott
SII
$2.66B
| $1.51M | ﹤0.01% |
+46,751
| New | +$1.62M |
|
3646
Ziff Davis
ZD
$1.96B
| $1.51M | ﹤0.01% |
+21,615
| New | +$1.48M |
|
|
GTHX
3647
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.51M | ﹤0.01% |
608,065
-267,069
| -31% | -$730K |
|
3648
Bank7 Corp
BSVN
$479M
| $1.51M | ﹤0.01% |
61,700
+3,953
| +7% | +$93.9K |
|
3649
Arteris
AIP
$1.38B
| $1.51M | ﹤0.01% |
+221,514
| New | +$1.2M |
|
3650
Patrick Industries
PATK
$2.74B
| $1.51M | ﹤0.01% |
28,307
-24,733
| -47% | -$1.16M |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.